Overview
Evaluate provides pharmaceutical commercial and pipeline intelligence to industry-leading companies of all sizes, including 82% of the top 100 pharma companies. Our online subscription services radically transform our clients’ confidence in strategic decisions by delivering a seamless, trusted view of the global pharmaceutical market in a single, standardized platform, including: consensus forecasts and historic sales, net present value, R&D pipelines, product-specific probability of success, R&D costs, clinical timelines and outcomes, company financials, deal records, catalyst events and more. Evaluate Vantage – our independent, award-winning editorial team – offers daily, data-driven news and analysis of key market events. For more information visit www.evaluate.com. On Twitter: @EvaluatePharma, @EvaluateVantage